Fantasy Football

Smith & Nephew threatens to sue Plus bosses

Medical devices group says it discovered 'unacceptable sales practices' after paying £457 million for orthopaedics firm

Recount demand over voting for Yahoo! board

Shareholders, including Carl Icahn, the billionaire who takes a seat on the board, believe Jerry Yang should be replaced

Carl Icahn says bid for Imclone too low

The Imclone chairman said that he and the rest of the board have decided to reject the $4.5bn offer from Bristol-Myers

Alzheimer drug puts TauRx on biotech map

TauRx Therapeutics, the drug company and manufacturer of Rember drug, has found itself at the centre of global attention

'I would never know who's in the Priory'

Philip Scott: how he became a psychiatric nurse then a manager

AstraZeneca results aided by weak dollar

Anglo-Swedish drugs group sales are up by 3 per cent but US sales fell 4 per cent on competition from generics

Protein could hold clue to postnatal depression

A protein has been identified that may determine why some women suffer acute depression after giving birth

Sharewatch: Stomach upset at Alizyme

New boss Andrew Witty revamps Glaxo Smith Kline

GSK's new chief executive is overhauling Europe's biggest drugs company

Rival snaps up UK assets of Patientline

The hospital communications provider was taken private in a deal that rendered shareholders’ investments worthless

Patientline collapses into administration

Stricken hospital telephone provider has been bought by new company Hospedia after calling in Deloitte & Touche

Bankers throw lifeline to stricken Southern Cross

UK's largest care homes operator is allowed to extend loan facilities until October to enable property assets sale

GSK to break up R&D operations

Alliance formed with Aspen of South Africa as under-pressure pharmaceuticals group announces plans for smaller R&D units

Roche bid for Genentech faces lawsuit

Roche’s $43.7bn (£21.8 bn) takeover of Genentech was met with a lawsuit claiming that the deal short-changed shareholders

GSK in tie-up with low-cost drugs group

Pharmaceuticals giant announces alliance with South African company to increase access to low cost generic drugs